R. Michael Carruthers, Chief Financial Officer at Edgewise Therapeutics, Inc. (EWTX), sold 1,314 shares at $16.45 ($22K) on 2025-05-02, disclosed to the SEC on 2025-05-07.
Seasonal sale ($22k) by Chief Financial Officer — this insider has traded EWTX in May in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| EWTX | SELL | 2024-05-03 | $41K | — | Filing → |
| EWTX | SELL | 2024-01-25 | $1.4M | — | Filing → |
| EWTX | SELL | 2023-05-03 | $12K | — | Filing → |